Page last updated: 2024-08-24

valsartan and Ventricular Dysfunction

valsartan has been researched along with Ventricular Dysfunction in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bao, Q; Li, G; Li, Y; Liu, T; Shao, S; Suo, Y; Wang, Y; Yang, Q; Yuan, M; Zhang, Y1
Chen, A; Chen, Z; Dong, Z; Fu, M; Ge, J; Hu, K; Qian, J; Sun, A; Xia, Y; Yang, X; Zou, Y1
Asselin, CY; Cheung, D; Czaykowski, P; Dingman, B; Edel, A; Goyal, V; Jassal, DS; Kim, E; Mittal, I; Mozolevska, V; Ravandi, A; Schwartz, A; Shaikh, B; Singal, PK; Thliveris, J1
Oliveira, GH; Robinson, MR1
Arnold, JM; Artis, E; Aurigemma, G; Daley, WL; Janardhanan, R; Mulvagh, SL; Naqvi, TZ; Purkayastha, D; Solomon, SD; Thomas, JD; Zile, M1
Al-Khatib, SM; Califf, RM; Kober, L; Lokhnygina, Y; McMurray, JJ; Solomon, SD; Thomas, KL; Velazquez, EJ1

Reviews

1 review(s) available for valsartan and Ventricular Dysfunction

ArticleYear
Contemporary clinical trial updates in heart failure.
    Current opinion in cardiology, 2016, Volume: 31, Issue:4

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Drug Combinations; Heart Failure; Heart Rate; Humans; Stroke Volume; Tetrazoles; Valsartan; Ventricular Dysfunction

2016

Trials

1 trial(s) available for valsartan and Ventricular Dysfunction

ArticleYear
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
    American heart journal, 2008, Volume: 155, Issue:1

    Topics: Aged; Amiodarone; Captopril; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Survival Analysis; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction

2008

Other Studies

4 other study(ies) available for valsartan and Ventricular Dysfunction

ArticleYear
Angiotensin receptor-neprilysin inhibitor attenuates cardiac hypertrophy and improves diastolic dysfunction in a mouse model of heart failure with preserved ejection fraction.
    Clinical and experimental pharmacology & physiology, 2022, Volume: 49, Issue:8

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cardiomegaly; Diastole; Disease Models, Animal; Drug Combinations; Heart Failure; Mice; Neprilysin; Receptors, Angiotensin; Stroke Volume; Tetrazoles; Valsartan; Ventricular Dysfunction

2022
LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy.
    Journal of molecular and cellular cardiology, 2017, Volume: 108

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Apoptosis; Biphenyl Compounds; Cardiomyopathy, Dilated; Cells, Cultured; Disease Models, Animal; Doxorubicin; Drug Combinations; Dynamins; Echocardiography; Female; Gene Expression; Humans; Male; Mice; Mitochondria; Myocytes, Cardiac; Tetrazoles; Valsartan; Ventricular Dysfunction

2017
Role of renin-angiotensin system antagonists in the prevention of bevacizumab- and sunitinib-mediated cardiac dysfunction.
    American journal of physiology. Heart and circulatory physiology, 2019, 03-01, Volume: 316, Issue:3

    Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Antineoplastic Agents; Bevacizumab; Cardiotoxicity; Fumarates; Hydralazine; Male; Mice; Mice, Inbred C57BL; Perindopril; Renin-Angiotensin System; Sunitinib; Valsartan; Ventricular Dysfunction

2019
Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension.
    American heart journal, 2006, Volume: 152, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Comorbidity; Diastole; Double-Blind Method; Echocardiography, Doppler; Humans; Hypertension; Randomized Controlled Trials as Topic; Research Design; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction

2006